BeiGene, Ltd. has proposed to change its name to BeOne Medicines Ltd. The new name is subject to shareholder approval and, once approved, use of the name will be phased in over 2025. There may be instances where “BeiGene” or “BeOne” are used to describe the company during this transition period. BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.

General Description:

The position will report directly to the Executive Director (ED), Global Value, Access & Pricing (GVAP) Lead, Hematology, and will be responsible for developing GVAP strategies across the Hematology portfolio for assets as assigned by the ED, GVAP, Lead, Hematology.

This role may have responsibilities for pipeline or inline assets. For the purposes of this role, a “pipeline asset” is any internally developed or externally acquired or licensed asset for which no Company Leadership endorsement for making the first major regulatory filing has occurred. Under the above definition, an asset will remain a “pipeline asset” until approximately 9-12 months before the first regulatory filing. Once an asset makes that transition, it is considered “inline”, meaning future indications or line extensions fall within the scope of “inline”. The ED, GVAP, Lead Hematology, reserves the right to amend, modify, or reassign duties and responsibilities as necessary to meet the evolving needs of the organization.

With regard to any assigned “pipeline” related duties, the Director, GVAP, Hematology provides critical strategic insights and guidance to ensure pipeline assets meet future market access needs and maximize commercial potential. The person in this position will focus on identifying market access-related evidentiary gaps in clinical development plans that could result in a breadth of reimbursement inconsistent with planned labelled population(s) and/or pricing that does not sustainably support the business. The person in this role will work cross-functionally with relevant stakeholders to develop recommendations to close those gaps and/or for evidence generation that, if implemented, would result in optimizing reimbursement and pricing potential. The person in this role must be capable of estimating the impact of different clinical development scenarios on access and price potential. The person in this role will confer with the ED, GVAP, Lead Hematology, to determine how and when to disseminate GVAP analysis and recommendations. Furthermore, the position may also support portfolio prioritization exercises.

With regard to any assigned “inline” related duties, the Director, GVAP, Hematology, drives value demonstration and access preparation activities, ensuring comprehensive market access, pricing, and value strategies for each product, line extension or combination in close collaboration with the GVAP Pricing, Regional Access Leads and / or direct countries and HEOR team. For any asset covered by this role that is launching in its first indication, this role is critical in developing the overarching GVAP strategy throughout the asset’s lifecycle that optimizes Company opportunity whilst balancing against Company vision / mission regarding patient access and affordability. The role also leads the development of the P&R operational foundation (e.g., value messaging, launch readiness toolkits, pricing guidance, indication prioritization), upon which affiliate organizations will build local P&R execution and delivery plans. The individual will be the primary contact for all Access related needs raised by Regional and Country Access Teams. The Director ensures that the GVAP function consistently communicates franchise access, value, and reimbursement perspectives to drive and align commercial strategy development across all Regions and territories where the Company operates.

Regardless of “pipeline” or “inline” focus, this person in this role is critical in driving P&R success for the Company’s hematology portfolio and must leverage market access expertise and a deep understanding of the evolving needs of global payers.

Essential Functions of the job:

Pipeline Market Access Strategy Development:

• Lead the creation and implementation of global market access strategies for hematology pipeline products (typically but not exclusively Phase II and III assets), aligning with clinical and commercial goals.
• Collaborate cross-functionally to integrate access requirements into the development process, influencing trial design, endpoints, and evidence generation to meet payer needs.
• Lead the collection and aggregation of feedback from all regions in which the Company operates, and developing recommendations regarding clinical development and other evidence generation based on that feedback.
• At the discretion of the ED, GVAP Hematology, represent the GVAP Hematology perspective (aligned with Regions and/or focus markets and HEOR) to one or more governance or oversight bodies of the Company (e.g., GPT, GBT)

Value Proposition & Evidence Generation:

• Develop early value propositions that resonate with global payers and support future pricing, reimbursement, and access decisions.
• Work closely with Clinical, Medical Affairs, and Health Economics & Outcomes Research (HEOR) teams to shape clinical trial design and evidence-generation strategies that align with target market access requirements.
• Identify and prioritize evidence gaps; work closely with HEOR to ensure development of health economic models, burden-of-illness studies, and other data to address payer concerns and enhance product differentiation.

Market Access Strategy & Execution:

• Lead the development and implementation of global market access strategies for in-market hematology products, line extensions, and near-launch products as of regulatory filing.
• Establish comprehensive value propositions that align with brand strategy and resonate with key payers, health systems, and other stakeholders.
• Work cross-functionally to ensure alignment with R&D, Medical Affairs, Commercial, and other teams on access strategies that maximize patient access and support global revenue goals.
• At the discretion of the ED, GVAP Hematology, represent the GVAP Hematology perspective (aligned with Regions and/or focus markets and HEOR) to one or more governance or oversight bodies of the Company (e.g., GPT, GBT), as needed throughout the assets lifecycle once it is “in-line.”

Launch Preparation & Value Toolkit Development:

• Drive launch readiness activities for products leaving the pipeline, starting from regulatory filing through to market launch, ensuring each product has a compelling value proposition for payers.
• Develop and deliver value toolkits— in close collaboration with HEOR - including health economic models, budget impact analyses, value dossiers, and payer engagement materials—tailored to meet the needs of regional and local market access teams.
• Collaborate with Medical Affairs, Clinical Development, and HEOR (Health Economics and Outcomes Research) teams to ensure evidence generation plans support the access strategy and payer requirements.
• Collaborate closely with SD EUHTA to develop compelling JCA dossier

In-Market Product & Line Extension Support:

• Manage global market access strategies for in-market hematology products, addressing lifecycle management opportunities, including new indications, line extensions, combinations, and product differentiation initiatives.
• Conduct ongoing assessments of payer feedback, competitive dynamics, and market conditions to refine access strategies and value messaging for existing products.
• Coordinate with regional and affiliate teams to adapt global access strategies for local markets, ensuring alignment with local pricing regulations, reimbursement policies, payer expectations, and Global brand strategy.

Cross-Functional Collaboration & Stakeholder Engagement:

• If delegated by ED, GVAP Hematology, serve as the primary market access point of contact for one or more Global Product Teams (GPTs).
• Collaborate with R&D, Commercial, Medical Affairs, and Regulatory Affairs to ensure access-related insights and payer needs are integrated into the overall development strategy.
• Provide input into clinical decisions and Business Development to ensure payer requirements are recognized, addressed and or additional evidence generated through other means, in support of the commercial strategy development expectations, trends and risks.
• Engage with focus markets and regional access teams to ensure early alignment on access strategies and support local adaptation for specific market needs.
• Working together with commercial, clinical, medical / HEOR and regional market access teams, align on early asset target product profile definitions and evidence required as well as planned value proposition that will support value positioning and reduce pricing and reimbursement uncertainties across all regions in which BeiGene operates.
• Serve as the primary point of contact for market access matters related to the in-market and close to launch products, fostering strong cross-functional alignment and communication.
• Collaborate closely with Pricing, HEOR, Medical Affairs, Commercial, and Regulatory Affairs to drive integrated access strategies and ensure successful product positioning across key markets.
• Liaise with Regional Access Leads of market access to collect, prioritize and communicate/ coordinate resource support requirements at a global level, regional and/or pan-regional requirements or needs for cross functional business partners (e.g., clinical biostatistics, medical, HEOR, etc.).
• Where required, support local market access efforts.

Pre-Launch Preparation:

• Drive pre-launch planning for pipeline products, including the creation of early value toolkits and JCA relevant PICOs and early engagement strategies to optimize future access and reimbursement.
• Support market access launch readiness through regular communication, training, and support to regional and affiliate teams, preparing them to engage with payers as the product nears market entry.
• Support regional activities relating to regional asset in-licensing for early pipeline products.

Market Insights & Competitive Landscape Analysis:

• Continuously monitor the hematology landscape, including competitor activities, evolving payer requirements, and regulatory changes that impact access and reimbursement.
• Run analysis of payer insights, pricing trends, and market conditions to inform strategy adjustments and refine access plans.
• Use global and regional insights to refine value propositions and enhance product positioning as the product advances through clinical phases.
• Lead early pipeline consultation processes with payers across all regions (in collaboration with the regions and/or focus markets) (e.g., CADTH, NICE, etc.)

Supervisory Responsibilities: No direct supervision, high level of cross functional and pan-regional collaborations with internal stakeholders

Education Required: Undergraduate science degree required. Post-graduate science degree (PhD, PharmD, MD) and/ or MBA preferred.

Computer Skills: Standard Computer Skills

Other Qualifications:

• Minimum of 10 years of related pharmaceutical experience is necessary with at least 5 years of direct experience in early asset pipeline/HEOR/Market Access functions.
• Experience in an HTA market is required.
• Extensive knowledge of US managed care is required.
• Launch experience is required.
• Detailed understanding of global pricing & reimbursement landscape, including the interrelation of various region pricing guidelines, HTA and national reimbursement process and requirements.
• Strong understanding of regional pricing requirements for coverage and reimbursement with the ability to manage complex cases and successfully address customer objections and questions.
• Knowledge of health technology assessment methods / health economics (HE) modeling is an advantage
• Ability to work effectively and communicate across multiple cultures and a breadth of functions and levels
• Analytical competencies to structure complex issues, synthesize key points and communicate and present in an easy-to-understand manner
• Strategic thinking, initiative, organization, prioritization and planning skills
• Fluency in English, both written and verbal, a second language is an advantage
• Strong customer focus in cross functional collaborations and teams, strong leadership and presentations skills with leadership across commercial and finance colleagues.
• Solid interpersonal skills including written and oral communication skills, ability to synthesize data, interpret and translate into compelling and clear commercial strategies and plans.
• Expertise and understanding of dynamic global market access value models such as value-based propositions and cost effectiveness models, etc.
• Capability of executing projects in timely fashion, getting things done rapidly.

Travel: 15% of time.

Global Competencies

When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.

• Fosters Teamwork
• Provides and Solicits Honest and Actionable Feedback
• Self-Awareness
• Acts Inclusively
• Demonstrates Initiative
• Entrepreneurial Mindset
• Continuous Learning
• Embraces Change
• Results-Oriented
• Analytical Thinking/Data Analysis
• Financial Excellence
• Communicates with Clarity

BeOne is committed to fair and equitable compensation practices. Actual compensation packages are determined by several factors that are unique to each candidate, including but not limited to job-related skills, depth of experience, certifications, relevant education or training, and specific work location. Packages may vary by location due to differences in the cost of labor. The recruiter can share more about the specific salary range for a preferred location during the hiring process. Please note that the listed range reflects the base salary or hourly range only. Non-Commercial roles are eligible to participate in the annual bonus plan, and Commercial roles are eligible to participate in an incentive compensation plan. All Company employees have the opportunity to own shares of BeiGene, Ltd. stock because all employees are eligible for discretionary equity awards and to voluntarily participate in the Employee Stock Purchase Plan. The Company has a comprehensive benefits package that includes Medical, Dental, Vision, 401(k), FSA/HSA, Life Insurance, Paid Time Off, and Wellness.

We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.